JOCELYN ESLICK: Open Payments
NPI 1730725649 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 40 payments from 6 companies in 2025. Trend: 2023 $884 · 2024 $1,377 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $400 |
| ABBVIE INC. | 15 | $203 |
| UCB, Inc. | 3 | $182 |
| GlaxoSmithKline, LLC. | 3 | $162 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
Products named: Bimzelx, BENLYSTA, KRYSTEXXA, TAVNEOS, SKYRIZI, RINVOQ, COSENTYX, VRAYLAR.
Industry payments across OK — which companies pay providers there.
